November 26, 2019
The American Society of Health-System Pharmacists drug shortage website indicates Lupin placed Ciprofloxacin oral suspension on long-term back order and the company cannot estimate a release date. This shortage affects NDCs 68180-0392-01 and 68180-0393-01, both preferred products. As of Nov. 19, VDP temporarily removed the non-preferred status from the following:
| Name | NDC |
|---|---|
| Cipro 5% Suspension | 50419-0777-01 |
| Cipro 10% Suspension | 50419-0773-01 |
This change will allow providers to prescribe these NDCs without requiring a PDL prior authorization and allow continued access to necessary medication. This change is temporary until the preferred products are sufficiently available in the market. Please contact vdp-formulary@hhsc.state.tx.us for questions.